Clinical Trials in København S, Denmark
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
ObesityOverweightAtherosclerotic Cardiovascular Disease
Amgen12,800 enrolled759 locationsNCT07037433
Recruiting
Phase 3
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109
Recruiting
PRIOR Study (Pre-eclampsia Risk In Oocyte Recipients)
Pre-EclampsiaPre-Eclampsia; Complicating PregnancyART+12 more
Copenhagen University Hospital, Hvidovre462 enrolled6 locationsNCT07263490